Integrated Analysis of Multiple Bioinformatics Studies to Identify MicroRNA-target Gene-transcription Factor Regulatory Networks in Retinoblastoma

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Aug 15

PMID 35966326

Authors

Yanjun Wen

Maolin Zhu

Xuerui Zhang

Haodong Xiao

Yan Wei

Peiquan Zhao

Affiliations

Soon will be listed here.

Abstract

Background: In children, retinoblastoma (RB) is one of the most common primary malignant ocular tumors and has a poor prognosis and high mortality. To understand the molecular mechanisms of RB, we identified microRNAs (miRNAs), key genes and transcription factors (TFs) using bioinformatics analysis to build potential miRNA-gene-TF networks.

Methods: We collected three gene expression profiles and one miRNA expression profile from the Gene Expression Omnibus (GEO) database. We used the limma R package to identify overlapping differentially expressed genes (DEGs) and differentially expressed miRNAs in RB tissues compared to noncancer tissues. The robust rank aggregation (RRA) method was implemented to identify key genes among the DEGs. Then, miRNA-key gene-TF networks were built using the online tools TransmiR and miRTarBase. Next, we used RT-qPCR to confirm the results.

Results: We identified 180 DEGs in RB tissues compared to nontumor tissues using integrative analysis, among which 109 genes were upregulated and 71 were downregulated. Gene ontology (GO) analysis revealed that these DEGs were primarily involved with chromosome segregation, condensed chromosome and DNA replication origin binding. The most highly enriched pathways obtained in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were cell cycle, DNA replication, homologous recombination, P53 signaling pathway and pyrimidine metabolism. Furthermore, two key differentially expressed miRNAs (DEMs) were also established: let-7a and let-7b. Finally, the potential regulatory networks of miRNA-target gene-TFs were examined.

Conclusions: This study identified key genes and built miRNA-target gene-TF regulatory networks in RB, which will deepen our understanding of the molecular mechanisms involved in the development of RB. These key genes and miRNAs may be potential targets and biomarkers for RB diagnosis and therapy.

Citing Articles

Retinoblastoma gene expression profiling based on bioinformatics analysis.

Mao J, Lu M, Lu S, Xing Y, Xu X, Chen Y BMC Med Genomics. 2023; 16(1):101.

PMID: 37179305 PMC: 10183129. DOI: 10.1186/s12920-023-01537-4.

Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective.

Shi P, Xie S, Yang J, Zhang Y, Han S, Su S Front Pharmacol. 2022; 13:1001553.

PMID: 36238572 PMC: 9553197. DOI: 10.3389/fphar.2022.1001553.

References

Dalgard C, Gonzalez M, deNiro J, OBrien J . Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest Ophthalmol Vis Sci. 2009; 50(10):4542-51. DOI: 10.1167/iovs.09-3520. View

Zhang Y, Wu J, Han F, Huang J, Shi S, Gu R . Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a. Neoplasma. 2013; 60(3):247-53. DOI: 10.4149/neo_2013_033. View

Lumbroso-Le Rouic L . Retinoblastoma. Rev Prat. 2018; 67(8):888-891. View

Zhao D, Cui Z . MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling. Exp Ther Med. 2019; 17(2):1154-1162. PMC: 6327618. DOI: 10.3892/etm.2018.7062. View

Castro-Magdonel B, Orjuela M, Camacho J, Garcia-Chequer A, Cabrera-Munoz L, Sadowinski-Pine S . miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma. BMC Cancer. 2017; 17(1):458. PMC: 5493862. DOI: 10.1186/s12885-017-3421-3. View

Yang J, Dang Y, Zhu Y, Zhang C . Diffuse anterior retinoblastoma: current concepts. Onco Targets Ther. 2015; 8:1815-21. PMC: 4516192. DOI: 10.2147/OTT.S79498. View

Zeng S, Liu A, Dai L, Yu X, Zhang Z, Xiong Q . Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms. BMC Cancer. 2019; 19(1):604. PMC: 6582551. DOI: 10.1186/s12885-019-5814-y. View

Chou C, Shrestha S, Yang C, Chang N, Lin Y, Liao K . miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2017; 46(D1):D296-D302. PMC: 5753222. DOI: 10.1093/nar/gkx1067. View

Portella G, Passaro C, Chieffi P . Aurora B: a new prognostic marker and therapeutic target in cancer. Curr Med Chem. 2010; 18(4):482-96. DOI: 10.2174/092986711794480203. View

10.

Zhao Q, Liu H, Yao C, Shuai J, Sun X . Effect of Dynamic Interaction between microRNA and Transcription Factor on Gene Expression. Biomed Res Int. 2016; 2016:2676282. PMC: 5121577. DOI: 10.1155/2016/2676282. View

11.

Wilson E, Sultana N, Shah K, Elford H, Faridi J . Molecular Targeting of RRM2, NF-κB, and Mutant TP53 for the Treatment of Triple-Negative Breast Cancer. Mol Cancer Ther. 2021; 20(4):655-664. DOI: 10.1158/1535-7163.MCT-20-0373. View

12.

Mononen N, Lyytikainen L, Seppala I, Mishra P, Juonala M, Waldenberger M . Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes. Sci Rep. 2019; 9(1):8887. PMC: 6586838. DOI: 10.1038/s41598-019-43793-4. View

13.

Yang M, Li Y, Wei W . MicroRNA-188-5p Promotes Epithelial-Mesenchymal Transition by Targeting ID4 Through Wnt/β‑catenin Signaling in Retinoblastoma. Onco Targets Ther. 2019; 12:10251-10262. PMC: 6885564. DOI: 10.2147/OTT.S229739. View

14.

Wang L, Wang L, Li L, Zhang H, Lyu X . MicroRNA‑330 is downregulated in retinoblastoma and suppresses cell viability and invasion by directly targeting ROCK1. Mol Med Rep. 2019; 20(4):3440-3447. DOI: 10.3892/mmr.2019.10545. View

15.

Tang Y, Li M, Wang J, Pan Y, Wu F . CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2014; 127:67-72. DOI: 10.1016/j.biosystems.2014.11.005. View

16.

Zou X, Xia T, Li M, Wang T, Liu P, Zhou X . MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis. Cancer Biomark. 2020; 30(1):41-53. DOI: 10.3233/CBM-201547. View

17.

Rao R, Honavar S . Retinoblastoma. Indian J Pediatr. 2017; 84(12):937-944. DOI: 10.1007/s12098-017-2395-0. View

18.

Zhang Q, Huang H, Liu A, Li J, Liu C, Sun B . Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells. EBioMedicine. 2019; 42:397-407. PMC: 6491421. DOI: 10.1016/j.ebiom.2019.03.032. View

19.

Liu X, Li X, Li J . MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1. Kaohsiung J Med Sci. 2020; 37(4):286-293. DOI: 10.1002/kjm2.12337. View

20.

Huang Z, Cao Y, Zhou M, Qi X, Fu B, Mou Y . Hsa_circ_0005519 increases IL-13/IL-6 by regulating hsa-let-7a-5p in CD4 T cells to affect asthma. Clin Exp Allergy. 2019; 49(8):1116-1127. DOI: 10.1111/cea.13445. View